Overview

Memantine for Agitation in Dementia

Status:
Unknown status
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
We plan to evaluate the use of memantine in Alzheimer's disease to control agitation in the acute situation i.e under 12 weeks
Phase:
Phase 4
Details
Lead Sponsor:
East Kent Hospitals University NHS Foundation Trust
Collaborators:
Indiana University School of Medicine
Institute of Psychiatry, London
University College, London
University of London
University of Oxford
Treatments:
Memantine